코어라인소프트
Financials
Valuation Metrics
코어라인소프트's Market Cap is ₩464B. At end of 2025 it was ₩732B. Ranked #1803 of 2,436 in KR market (top 74%), #1101 of 1,649 on KOSDAQ (top 67%), #74 of 96 in Health Care Equipment & Services (top 77%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 46.39B KRW | KR#1,803/2,436 Sec#74/96 |
| Revenue | 4.71B KRW | KR#2,350/2,436 Sec#89/96 |
| Net Income | -13.77B KRW | KR—/2,436 Sec—/96 |
| Total Assets | 51.25B KRW | KR#2,183/2,436 Sec#75/96 |
| Net Assets | 16.61B KRW | KR#2,318/2,436 Sec#92/96 |
| Employees | 101 | KR#1,615/2,436 Sec#57/96 |
| Value | ||
| P/B | 2.79x | KR#2,089/2,436 Sec#77/96 |
| P/S | 9.85x | KR#2,268/2,436 Sec#83/96 |
| FCF Yield | -25.51% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | -82.89% | KR#2,325/2,436 Sec#90/96 |
| ROA | -26.87% | KR#2,272/2,436 Sec#85/96 |
| Op. Margin | -272.84% | KR#2,356/2,436 Sec#91/96 |
| Revenue Growth | 48.71% | KR#307/2,436 Sec#10/96 |
| Financial Health | ||
| Debt Ratio | 308.52% | KR#2,151/2,436 Sec#88/96 |
| Total Debt | 20.17B KRW | KR#1,352/2,436 Sec#40/96 |
| FCF | -11.83B KRW | KR#1,760/2,436 Sec#66/96 |
| Cash | 16.59B KRW | KR#1,360/2,436 Sec#41/96 |
| Current Ratio | 1.77x | KR#1,102/2,436 Sec#58/96 |
| Performance | ||
| 1Y Return | -47.62% | KR#2,044/2,436 Sec#73/96 |
| 1M Return | -14.55% | KR#2,020/2,436 Sec#78/96 |
| From 52W High | -53.17% | KR#1,380/2,436 Sec#53/96 |
| 1Y MDD | -65.63% | KR#1,731/2,436 Sec#59/96 |
| Trading | ||
| Volume | 57,619 shares | KR#1,438/2,436 Sec#62/96 |
| Foreign Own. | 4.42% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | -794 KRW | KR—/2,436 Sec—/96 |
| BPS | 904 KRW | KR#2,304/2,436 Sec#88/96 |
Company Info
Established in 2012, Coreline Soft is an AI-based 3D medical image analysis solution company that has entered global markets through European and US subsidiaries. Under its AVIEW brand, the company provides diagnostic assistance services including chest and head and neck CT image analysis, lung cancer screening, chronic obstructive pulmonary disease, and coronary artery calcification. By securing projects with institutions like the National Cancer Center, it leads the global lung cancer screening market and generates customer loyalty through optimized AI technology and user experience. Coreline Soft is headquartered in Mapo-gu, Seoul.